IL2 and autoimmune disease: Alternatively, for the treatment of autoimmune diseases, investigators sought to expand Treg cells that efficiently express IL-2Rαβγ by masking the binding sites of IL-2 to CD122 and CD132, only exposing the binding sites to CD25 (26).